Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	777	1,291	614	2,966	1,749	1,910
Market Cap Growth	-53.63%	110.30%	-79.30%	69.58%	-8.45%	233.24%
Enterprise Value	545	1,038	233	2,508	1,359	1,604
PE Ratio	-	-16.55	-5.67	-16.39	-17.03	-21.61
PS Ratio	4.06	7.36	4.58	65.03	34.89	6006.96
PB Ratio	2.16	3.42	1.51	6.19	4.29	6.40
P/FCF Ratio	-35.15	-37.77	-7.69	-18.63	-22.65	-29.99
P/OCF Ratio	-35.54	-38.58	-7.72	-18.81	-25.03	-30.04
EV/Sales Ratio	2.85	5.91	1.74	55.00	27.11	5044.64
EV/EBITDA Ratio	-11.78	-16.47	-2.24	-14.14	-13.40	-18.42
EV/EBIT Ratio	-8.55	-13.90	-2.19	-13.92	-13.22	-18.18
EV/FCF Ratio	-23.93	-30.37	-2.91	-15.76	-17.60	-25.19
Debt / Equity Ratio	0.25	0.26	0.02	0.02	0.02	-
Debt / EBITDA Ratio	-2.11	-1.55	-0.08	-0.05	-0.08	-
Debt / FCF Ratio	-4.30	-2.86	-0.10	-0.05	-0.11	-
Quick Ratio	4.91	4.85	8.74	11.85	12.45	27.13
Current Ratio	5.61	5.50	9.60	12.63	13.11	27.90
Asset Turnover	0.35	0.33	0.28	0.11	0.13	0.00
Interest Coverage	-14.21	-26.92	-	-	-	-
Return on Equity (ROE)	-16.40%	-20.10%	-25.40%	-48.90%	-31.40%	-51.40%
Return on Assets (ROA)	-11.50%	-14.80%	-22.20%	-42.40%	-26.70%	-44.70%
Return on Capital (ROIC)	-16.82%	-19.28%	-26.96%	-37.05%	-25.06%	-30.46%
Earnings Yield	-8.06%	-6.04%	-17.62%	-6.10%	-5.87%	-4.63%
FCF Yield	-2.65%	-2.65%	-13.00%	-5.37%	-4.41%	-3.33%
Buyback Yield / Dilution	-0.96%	-0.93%	-9.70%	-9.20%	-27.36%	-9.72%
Total Shareholder Return	-0.96%	-0.93%	-9.70%	-9.20%	-27.36%	-9.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).